This inventor holds 1 USPTO granted patent. Top assignee: Sterling Drug Inc.. Active years: 1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980
Title: The Innovations of Homer R. Harding
Introduction
Homer R. Harding is a notable inventor based in Canaan, NY (US). He has made significant contributions to the field of medicine, particularly in the area of hormonal regulation. His work has led to advancements that may impact therapeutic approaches in endocrinology.
Latest Patents
Homer R. Harding holds a patent for a method titled "Pituitary-adrenal inhibiting method." This innovative method involves suppressing pituitary-adrenal function without producing peripheral glucocorticoid effects in a primate. The patent discloses the administration of (17.alpha.)-2'-(4-fluorophenyl)-2'H-pregna-2,4-dien-20-yno[3,2-c]-pyrazol-17-ol, which is effective in reducing the concentration of circulating hydrocortisone.
Career Highlights
Throughout his career, Harding has been associated with Sterling Drug Inc., where he has contributed to various research initiatives. His work has been instrumental in developing methods that could lead to improved treatments for conditions related to adrenal function.
Collaborations
Homer R. Harding has collaborated with notable colleagues, including John E. Creange and Harry P. Schane, Jr. These partnerships have fostered an environment of innovation and have contributed to the success of their projects.
Conclusion
Homer R. Harding's contributions to the field of medicine through his innovative patent demonstrate his commitment to advancing healthcare solutions. His work continues to inspire future research and development in endocrinology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile